BiondVax Receives $2.8 million Investment from Marius Nacht fund
BiondVax Pharmaceuticals Ltd. has announce that Angels High Tech Investments Ltd. has agreed to invest NIS 10.9 million, (approx $2.83 million), in exchange for 33.8 million ordinary BiondVax shares More...
Universal flu vaccine is world health game-changer
Is flu about to be eradicated once and for all? Dr. Ron Babecoff, the CEO and founder of Israeli company BiondVax, which has patented a vaccine with potential to banish every strain of flu, certainly More...
Independent Results: BiondVax’s Universal Flu Vaccine Administered in a Trial 3 years ago Improves Immunogenicity against Current Flu Vaccine
BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV, TASE: BVXV) received the statistical analysis of results from a study which demonstrates that BiondVax’s universal flu vaccine (M-001), administered More...
Universal flu vaccine co BiondVax mulls NY IPO
– BiondVax is exploring two options – either a conventional offering or listing American Depositary Receipts. – Universal flu vaccine developer BiondVax Pharmaceuticals Ltd. (TASE:BNDX) More...
Israeli BiondVax Gets $1.34 Million to Develop Universal Flu Vaccine
Israeli firm BiondVax, a biopharmaceutical company developing a Universal Flu Vaccine, has been awarded $1.34 million from Israel’s Chief Scientist in the Ministry of Economy to promote the company’s More...
Israeli Weizmann Institute of Science R&D company earns $50-100 million annually
– Products developed by the Weizmann Institute have $20 billion in annual sales. – – / By Gali Weinreb / The campus of the Weizmann Institute of Science gives a sense of abundance to those More...